01Historical material (the bulletin is dated 2025, and the Category III lab codes took effect July 1, 2025, so they are already in effect): Lab billing and charge entry staff should confirm that the codes added or revised for July 1, 2025 (0220U, 0522U, 0573U, 0560U, 0561U, 0569U, 0567U, 0420U, 0557U, 0562U, 0565U, 0566U, 0285U, 0393U, 0568U, 0574U, 0571U) are in charge entry with the revised descriptions, and that the tests are documented against the criteria in their cited BCBS SC policies.
02Anesthesia billing staff should note that the anesthesia policy (CAM 012) states the qualifying circumstance codes 99100, 99116, 99135 and 99140 and the risk factor modifiers P3, P4 and P5 are reimbursable only when billed with the AA or QZ modifier; add those modifiers in charge entry and claim edits.
03The bulletin does not state an effective date for this statement, so check the current CAM 012 text.
04Genetic testing staff should add 81403 and 81479 (CAM 281) and 81415, 81416, 81425 and 81426 (CAM 266) only where the cited policy criteria are documented; CAM 266 requires genetic counseling for epilepsy genetic testing.
05Fertility and ob-gyn staff should review the preimplantation genetic testing codes 89290 and 89291 (CAM 40204), which the policy covers for monogenic and single gene diseases.
06Ob-gyn staff should review code A9293 (CAM 094), which the bulletin adds for an FDA-approved contraception mobile application.
07The bulletin does not state effective dates for several additions, so do not assume a date.
08Because this bulletin is historical, check the current version of each cited BCBS SC policy before relying on it.
09Other annual reviews in the bulletin, with no change in policy intent, need no billing change.